Monocytic and granulocytic myeloid derived suppressor cells differentially regulate spatiotemporal tumour plasticity during metastatic cascade

Nature Communications

Volumn 8, Issue , 2017, Pages

  Ouzounova, Maria ^a   Lee, Eunmi ^a   Piranlioglu, Raziye ^a   El Andaloussi, Abdeljabar ^a   Kolhe, Ravindra ^a   Demirci, Mehmet F ^a   Marasco, Daniela ^b   Asm, Iskander ^a   Chadli, Ahmed ^a   Hassan, Khaled A ^b   Thangaraju, Muthusamy ^a   Zhou, Gang ^a   Arbab, Ali S ^a   Cowell, John K ^a   Korkaya, Hasan ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE 1; BETA1 INTEGRIN; CD24 ANTIGEN; CXCL16 CHEMOKINE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 12; INTERLEUKIN 6; INTERLEUKIN 8; NITRIC OXIDE SYNTHASE; RANTES; TRANSCRIPTOME; VASCULAR CELL ADHESION MOLECULE 1; VIMENTIN;

CANCER; CELLS AND CELL COMPONENTS; EXPERIMENTAL STUDY; GENE; GENETIC ANALYSIS; GROWTH; PHENOTYPE; RODENT; SURVIVAL; TUMOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER SURVIVAL; CELL DIFFERENTIATION; CELL EXPANSION; CELL INFILTRATION; CELL PLASTICITY; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; GRANULOCYTE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LUNG METASTASIS; METASTASIS; MONOCYTE; MOUSE; MYELOID-DERIVED SUPPRESSOR CELL; NONHUMAN; PHENOTYPE; SPLENOMEGALY; TRANSCRIPTOMICS; TRIPLE NEGATIVE BREAST CANCER; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CELL CULTURE; CELL PROLIFERATION; EXPERIMENTAL MAMMARY NEOPLASM; FEMALE; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; NEOPLASM; PATHOLOGY; PROCEDURES; TUMOR CELL LINE;

ANIMALIA; MURINAE;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; GENE EXPRESSION PROFILING; GRANULOCYTES; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE, INBRED BALB C; MICE, INBRED C57BL; MONOCYTES; MYELOID-DERIVED SUPPRESSOR CELLS; NEOPLASM METASTASIS; NEOPLASMS;

EID: 85017186697     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms14979     Document Type: Article

References (40)

1. Husemann, Y. et al. Systemic spread is an early step in breast cancer. Cancer Cell 13, 58-68 (2008).
2. Nguyen, D. X., Bos, P. D. & Massague, J. Metastasis: from dissemination to organ-specific colonization. Nat. Rev. Cancer 9, 274-284 (2009).
3. Klein, C. A. Parallel progression of primary tumours and metastases. Nat. Rev. Cancer 9, 302-312 (2009).
4. Paget, S. The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastat. Rev. 8, 98-101 (1989).
5. Fidler, I. J. Tumor heterogeneity and the biology of cancer invasion and metastasis. Cancer Res. 38, 2651-2660 (1978).
6. Fidler, I. J. & Kripke, M. L. Metastasis results from preexisting variant cells within a malignant tumor. Science 197, 893-895 (1977).
7. Soundararajan, R., Paranjape, A. N., Barsan, V., Chang, J. T. & Mani, S. A. A novel embryonic plasticity gene signature that predicts metastatic competence and clinical outcome. Sci. Rep. 5, 11766 (2015).
8. Grunert, S., Jechlinger, M. & Beug, H. Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. Nat. Rev. Mol. Cell Biol. 4, 657-665 (2003).
9. Tsai, J. H., Donaher, J. L., Murphy, D. A., Chau, S. & Yang, J. Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. Cancer Cell 22, 725-736 (2012).
10. Tan, T. Z. et al. Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients. EMBO Mol. Med. 6, 1279-1293 (2014).
11. Chikaishi, Y., Uramoto, H. & Tanaka, F. The EMT status in the primary tumor does not predict postoperative recurrence or disease-free survival in lung adenocarcinoma. Anticancer Res. 31, 4451-4456 (2011).
12. Marvel, D. & Gabrilovich, D. I. Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected. J. Clin. Invest. 125, 3356-3364 (2015).
13. Condamine, T., Ramachandran, I., Youn, J. I. & Gabrilovich, D. I. Regulation of tumor metastasis by myeloid-derived suppressor cells. Annu. Rev. Med. 66, 97-110 (2015).
14. Kaur, P. et al. A mouse model for triple-negative breast cancer tumor-initiating cells (TNBC-TICs) exhibits similar aggressive phenotype to the human disease. BMC Cancer 12, 120 (2012).
15. Aslakson, C. J. & Miller, F. R. Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res. 52, 1399-1405 (1992).
16. Erin, N. et al. Bidirectional effect of CD200 on breast cancer development and metastasis, with ultimate outcome determined by tumor aggressiveness and a cancer-induced inflammatory response. Oncogene 34, 3860-3870 (2014).
17. Shackleton, M. et al. Generation of a functional mammary gland from a single stem cell. Nature 439, 84-88 (2006).
18. Marotta, L. L. et al. The JAK2/STAT3 signaling pathway is required for growth of CD44()CD24 stem cell-like breast cancer cells in human tumors. J. Clin. Invest. 121, 2723-2735 (2011).
19. Kim, G. et al. SOCS3-mediated regulation of inflammatory cytokines in PTEN and p53 inactivated triple negative breast cancer model. Oncogene 34, 671-680 (2014).
20. Boyle, K. et al. The SOCS box of suppressor of cytokine signaling-3 contributes to the control of G-CSF responsiveness in vivo. Blood 110, 1466-1474 (2007).
21. Croker, B. A. et al. SOCS3 is a critical physiological negative regulator of G-CSF signaling and emergency granulopoiesis. Immunity 20, 153-165 (2004).
22. Hermans, M. H. et al. Signaling mechanisms coupled to tyrosines in the granulocyte colony-stimulating factor receptor orchestrate G-CSF-induced expansion of myeloid progenitor cells. Blood 101, 2584-2590 (2003).
23. Weng, Y. R., Cui, Y. & Fang, J. Y. Biological functions of cytokeratin 18 in cancer. Mol. Cancer Res. 10, 485-493 (2012).
24. Fenner, J. et al. Macroscopic stiffness of breast tumors predicts metastasis. Sci. Rep. 4, 5512 (2014).
25. Waight, J. D., Hu, Q., Miller, A., Liu, S. & Abrams, S. I. Tumor-derived G-CSF facilitates neoplastic growth through a granulocytic myeloid-derived suppressor cell-dependent mechanism. PLoS ONE 6, e27690 (2011).
26. Bergenfelz, C. et al. Systemic monocytic-MDSCs are generated from monocytes and correlate with disease progression in breast cancer patients. PLoS ONE 10, e0127028 (2015).
27. Oh, K. et al. A mutual activation loop between breast cancer cells and myeloid-derived suppressor cells facilitates spontaneous metastasis through IL-6 trans-signaling in a murine model. Breast. Cancer Res. 15, R79 (2013).
28. Cheung, K. J., Gabrielson, E., Werb, Z. & Ewald, A. J. Collective invasion in breast cancer requires a conserved basal epithelial program. Cell 155, 1639-1651 (2013).
29. Mani, S. A. et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133, 704-715 (2008).
30. Talmadge, J. E. & Gabrilovich, D. I. History of myeloid-derived suppressor cells. Nat. Rev. Cancer 13, 739-752 (2013).
31. Gao, J. et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal. 6, pl1 (2013).
32. Cerami, E. et al. The cBio cancer genomics portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2, 401-404 (2012).
33. Whitfield, M. L., George, L. K., Grant, G. D. & Perou, C. M. Common markers of proliferation. Nat. Rev. Cancer 6, 99-106 (2006).
34. Gabrilovich, D. I. & Nagaraj, S. Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9, 162-174 (2009).
35. Korkaya, H., Liu, S. & Wicha, M. S. Breast cancer stem cells, cytokine networks, and the tumor microenvironment. J. Clin. Invest. 121, 3804-3809 (2011).
36. Eyler, C. E. et al. Glioma stem cell proliferation and tumor growth are promoted by nitric oxide synthase-2. Cell 146, 53-66 (2011).
37. Karnoub, A. E. et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449, 557-563 (2007).
38. Quail, D. F. & Joyce, J. A. Microenvironmental regulation of tumor progression and metastasis. Nat. Med. 19, 1423-1437 (2013).
39. Kang, Y. & Pantel, K. Tumor cell dissemination: emerging biological insights from animal models and cancer patients. Cancer Cell 23, 573-581 (2013).
40. Dontu, G. et al. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev. 17, 1253-1270 (2003).